Utility of a Single Itch-Related Question and the Skindex-10 Questionnaire for Assessing Pruritus and Predicting Health-Related Quality of Life in Patients Receiving Hemodialysis.

Hemodialysis itch patient-reported outcomes pruritus quality of life

Journal

Kidney medicine
ISSN: 2590-0595
Titre abrégé: Kidney Med
Pays: United States
ID NLM: 101756300

Informations de publication

Date de publication:
Jun 2022
Historique:
entrez: 2 6 2022
pubmed: 3 6 2022
medline: 3 6 2022
Statut: epublish

Résumé

Chronic kidney disease-associated pruritus has been linked with poorer mental and physical health-related quality of life (HR-QOL) in patients receiving hemodialysis. We used the Skindex-10 questionnaire and a single itch-related question to evaluate their prediction of HR-QOL. Prospective, international cohort. We analyzed data from 4,940 patients receiving hemodialysis from 17 countries enrolled in phase 5 (2013) of the Dialysis Outcomes and Practice Patterns Study. The responses to the 10 questions of Skindex-10 (0-6 scale) pertaining to itchiness in the past week were summed to create a summary score (range, 0-60). Concurrently, a single question from the Kidney Disease Quality of Life 36-item survey asked "during the past 4 weeks, to what extent were you bothered by itchy skin?" with 5 responses, ranging from "not at all" to "extremely" bothered. Physical component summary (PCS) and mental component summary (MCS) scores of HR-QOL. We used separate linear regression models to evaluate the predictive power, based on R The correlation between the single itch-related question and the Skindex-10 score was 0.72. A 10-point higher Skindex-10 score was associated with a 1.2-point lower PCS score (95% CI, -1.4 to -0.9) and a 1.5-point lower MCS score (95% CI, -1.7 to -1.3) . The R Measurement bias and translation issues in the questionnaires. The single question about the extent to which the patients were bothered by itchy skin was highly correlated with the Skindex-10 score and at least as predictive of key HR-QOL measures. In daily clinical practice, using 1 simple question about the extent to which patients are bothered by itchy skin can be a feasible and efficient method for the routine assessment of pruritus.

Identifiants

pubmed: 35651592
doi: 10.1016/j.xkme.2022.100476
pii: S2590-0595(22)00090-5
pmc: PMC9149192
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100476

Informations de copyright

© 2022 The Authors.

Références

Qual Life Res. 2012 May;21(4):603-12
pubmed: 21744033
Kidney Med. 2020 Nov 21;3(1):42-53.e1
pubmed: 33604539
J Am Acad Dermatol. 2017 Dec;77(6):1068-1073.e7
pubmed: 29033248
Clin J Am Soc Nephrol. 2007 Sep;2(5):960-7
pubmed: 17702730
Am J Kidney Dis. 2017 Nov;70(5):638-655
pubmed: 28720208
Kidney Int. 2015 Apr;87(4):685-91
pubmed: 24402092
Nephrol Dial Transplant. 2006 Dec;21(12):3495-505
pubmed: 16968725
Kidney Int. 2009 Nov;76(9):946-52
pubmed: 19675529
Br J Dermatol. 2015 Jun;172(6):1541-1546
pubmed: 25630690
J Psychosom Res. 2016 Dec;91:12-19
pubmed: 27894457
Am J Kidney Dis. 1997 May;29(5):658-68
pubmed: 9159298
Nephron Clin Pract. 2012;122(3-4):75-9
pubmed: 23548570
Med Care. 1996 Mar;34(3):220-33
pubmed: 8628042
Qual Life Res. 1994 Oct;3(5):329-38
pubmed: 7841967
Clin J Am Soc Nephrol. 2010 Aug;5(8):1410-9
pubmed: 20558560
Br J Dermatol. 2009 Aug;161(2):384-9
pubmed: 19298271
Cochrane Database Syst Rev. 2020 Dec 7;12:CD011393
pubmed: 33283264
Kidney Int. 2002 Jun;61(6):2266-71
pubmed: 12028469
Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2000-2007
pubmed: 28923831
Clin J Am Soc Nephrol. 2014 Oct 7;9(10):1813-21
pubmed: 24832095
Nephrol Dial Transplant. 2017 Dec 1;32(12):1963-1966
pubmed: 29126280
Eur J Dermatol. 2018 Aug 1;28(4):488-495
pubmed: 29976533
Clin J Am Soc Nephrol. 2019 May 7;14(5):673-681
pubmed: 30975656
Hemodial Int. 2018 Jan;22(1):103-109
pubmed: 28263039
An Bras Dermatol. 2011 Jan-Feb;86(1):31-6
pubmed: 21437519
Nephrol Dial Transplant. 2002 Dec;17(12):2164-9
pubmed: 12454228
Nephrol Dial Transplant. 2009 Apr;24(4):1328-30
pubmed: 19155533

Auteurs

Marcelo Barreto Lopes (MB)

Arbor Research Collaborative for Health, Ann Arbor, MI.

Angelo Karaboyas (A)

Arbor Research Collaborative for Health, Ann Arbor, MI.

Nidhi Sukul (N)

Department of Internal Medicine, Division of Nephrology, University of Michigan, Ann Arbor, MI.
Division of Nephrology, Veterans Affairs Ann Arbor Health System, Ann Arbor, MI.

Kazuhiko Tsuruya (K)

Department of Integrated Therapy for Chronic Kidney Disease, Kyushu University, Fukuoka, Japan.

Issa Al Salmi (I)

The Royal Hospital, Muscat, Oman.

Elham Asgari (E)

Department of Nephrology, Guy's, St Thomas Hospital, London, United Kingdom.

Anas Alyousef (A)

Nephrology Division, Farwaniya Hospital, Kuwait City, Kuwait.

Thilo Schaufler (T)

Vifor Pharma Ltd, Glattbrugg, Switzerland.

Sebastian Walpen (S)

Vifor Pharma Ltd, Glattbrugg, Switzerland.

Frederique Menzaghi (F)

Cara Therapeutics, Inc, Stamford, CT.

Ronald Pisoni (R)

Arbor Research Collaborative for Health, Ann Arbor, MI.

Classifications MeSH